{"id":3973,"date":"2023-01-18T11:38:53","date_gmt":"2023-01-18T10:38:53","guid":{"rendered":"https:\/\/www.socesfar.es\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/"},"modified":"2024-04-23T10:37:44","modified_gmt":"2024-04-23T08:37:44","slug":"actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022","status":"publish","type":"revista","link":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/","title":{"rendered":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 20, n\u00ba 3\/4, 2022"},"content":{"rendered":"\n<p><strong>20 A\u00d1OS DE AFT<\/strong><\/p>\n\n<p><strong><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/00AFTV20N34WEB_Actualidad_farmacologia_terapeutica_12_02_Op.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 20, n\u00ba 3\/4, 2022<\/a><\/strong><\/p>\n\n<p><strong>Indice<\/strong><\/p>\n\n<p><strong>EDITORIAL DEL PRESIDENTE<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-01-Edit-presidente.pdf\">La SEF y la revista AFT: veinte a\u00f1os de viaje conjunto<\/a><\/p>\n\n<p><strong>EDITORIAL DEL DIRECTOR<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-02-Edit-director.pdf\">Farmacolog\u00eda lagunera<\/a><\/p>\n\n<p><strong>EDITORIAL INVITADO<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03A-Editorial-invitado.pdf\">Innovations for remdesivir to remain in the game against COVID-19<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03C-Editorial-invitado.pdf\">Siguiendo la huella espacio temporal del ion Calcio<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03D-Editorial-invitado.pdf\">Innovaci\u00f3n abierta e incremental de medicamentos<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03E-Editorial-invitado.pdf\">A discussion on Statins use at the light of new 2022 recomendations<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03F-Editorial-invitado.pdf\">A prop\u00f3sito de una enfermedad \u201csin glamur\u201d llamada artrosis<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03G-Editorial-invitado.pdf\">Veinte A\u00f1os despu\u00e9s<\/a><\/p>\n\n<p><strong>ESPECIAL 20 A\u00d1OS DE AFT<\/strong><\/p>\n\n<p><strong>Editoriales de los presidentes de la SEF<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-A-Editorial-invitado.pdf\">Veinte A\u00f1os de AFT<\/a>. P<a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-A-Editorial-invitado.pdf\">rof. Antonio G. Garc\u00eda<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-B-Editorial-invitado.pdf\">Veinte A\u00f1os de AFT. Prof. Jes\u00fas Fl\u00f3rez Beledo<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-C-Editorial-invitado.pdf\">La Sociedad Espa\u00f1ola de Farmacolog\u00eda durante el periodo 1995-1997. Prof. Juan Tamargo Men\u00e9ndez<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-D-Editorial-invitado.pdf\">Veinte a\u00f1os de AFT.<\/a> <a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-D-Editorial-invitado.pdf\">Prof. Esteban Morcillo S\u00e1nchez<\/a><\/p>\n\n<p><a href=\"http:\/\/Reflexiones de un presidente de la SEF, entre siglos. Prof. Pedro S&#xE1;nchez Garc&#xED;a\">Reflexiones de un presidente de la SEF, entre siglos. P<\/a><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-E-Editorial-invitado.pdf\">rof. Pedro S\u00e1nchez Garc\u00eda<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-E-Editorial-invitado.pdf\">Veinte A\u00f1os de AFT.<\/a> <a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-F-Editorial-invitado.pdf\">Prof. Francisco Zaragoz\u00e1 Garc\u00eda<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-G-Editorial-invitado.pdf\">La Sociedad Espa\u00f1ola de Farmacolog\u00eda durante el periodo 2009-2014.<\/a> <a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-G-Editorial-invitado.pdf\">Profa. Teresa Tejerina<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-H-Editorial-invitado.pdf\">Veinte A\u00f1os de AFT<\/a>. P<a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-03Z-H-Editorial-invitado.pdf\">rofa. Mar\u00eda Jes\u00fas Sanz<\/a><\/p>\n\n<p><strong>INVESTIGACI\u00d3N TRASLACIONAL<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-05A-Inv-traslacional.pdf\">El canal TMEM 16A: perspectives terap\u00e9uticas<\/a><\/p>\n\n<p><strong>DOCENCIA EN FARMACOLOG\u00cdA<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-08-Docencia-en-farmacologia.pdf\">Red de innovaci\u00f3n docente interuniversitaria en farmacolog\u00eda An e-learning authoring tool for Pharmacology teaching<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-08B-Docencia-en-farmacologia.pdf\">An e-learning authoring tool for Pharmacology teaching<\/a><\/p>\n\n<p><strong>NOVEDADES TERAP\u00c9UTICAS<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-10-1-Novedades-Ter.pdf\">La Agencia Europea del Medicamento aprueba el primer antagonista selectivo de los receptores de orexina para el tratamiento del insomino<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-10-2-Novedades-Ter.pdf\">Aprobada la utilizaci\u00f3n de la coformulaci\u00f3n de fenilbutirato de sodio y ursodoxicoltaurina para el tratamiento de la esclerosis lateral amiotr\u00f3fica (ELA)<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-10-3-Novedades-Ter.pdf\">La FDA ha aprobado el uso de la soluci\u00f3n oft\u00e1lmica Isopropilo de Omidenepag para el tratamiento del glaucoma<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-10-4-Novedades-Ter.pdf\">Abrocitinib, nuevo f\u00e1rmaco para tratar la dermatitis at\u00f3pica en adultos<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-10-5-Novedades-Ter.pdf\">Tapinarof, un agonista del receptor de hidrocarburos de arilo para el tratamiento de la psoriasis en adultos<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/AFTV20N3_4-10-6-Novedades-Ter.pdf\">Se aprueba el uso de amivantamab para pacientes con c\u00e1ncer de pulm\u00f3n avanzado con inserciones en el ex\u00f3n 20 del gen EGFR<\/a><\/p>\n\n<p><a href=\"http:\/\/3_4-10-7-Novedades-Ter.pdf\">Aprobada la utilizaci\u00f3n de pimitespib para el tratamiento de tumores de estroma gastrointestinales<\/a><\/p>\n\n<p><\/p>\n","protected":false},"featured_media":3952,"template":"","categoria_revista":[95],"class_list":["post-3973","revista","type-revista","status-publish","has-post-thumbnail","hentry","categoria_revista-2022-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 20, n\u00ba 3\/4, 2022 - Sociedad Espa\u00f1ola de Farmacolog\u00eda<\/title>\n<meta name=\"description\" content=\"20 A\u00d1OS DE AFTActualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 20, n\u00ba 3\/4, 2022 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"og:description\" content=\"20 A\u00d1OS DE AFTActualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-23T08:37:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/portada.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"456\" \/>\n\t<meta property=\"og:image:height\" content=\"645\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Socesfar\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\\\/\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\\\/\",\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 20, n\u00ba 3\\\/4, 2022 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/portada.jpg\",\"datePublished\":\"2023-01-18T10:38:53+00:00\",\"dateModified\":\"2024-04-23T08:37:44+00:00\",\"description\":\"20 A\u00d1OS DE AFTActualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/portada.jpg\",\"contentUrl\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/portada.jpg\",\"width\":456,\"height\":645},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revistas\",\"item\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revistas\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 20, n\u00ba 3\\\/4, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#organization\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/logo-socesfar-02.png\",\"contentUrl\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/logo-socesfar-02.png\",\"width\":383,\"height\":63,\"caption\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/Socesfar\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/socesfar\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 20, n\u00ba 3\/4, 2022 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"20 A\u00d1OS DE AFTActualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/","og_locale":"en_US","og_type":"article","og_title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 20, n\u00ba 3\/4, 2022 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","og_description":"20 A\u00d1OS DE AFTActualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol.","og_url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/","og_site_name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","article_modified_time":"2024-04-23T08:37:44+00:00","og_image":[{"width":456,"height":645,"url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/portada.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@Socesfar","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/","url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/","name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 20, n\u00ba 3\/4, 2022 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","isPartOf":{"@id":"https:\/\/www.socesfar.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/#primaryimage"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/portada.jpg","datePublished":"2023-01-18T10:38:53+00:00","dateModified":"2024-04-23T08:37:44+00:00","description":"20 A\u00d1OS DE AFTActualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol.","breadcrumb":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/#primaryimage","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/portada.jpg","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/01\/portada.jpg","width":456,"height":645},{"@type":"BreadcrumbList","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-20-no-3-4-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.socesfar.es\/en\/"},{"@type":"ListItem","position":2,"name":"Revistas","item":"https:\/\/www.socesfar.es\/en\/revistas\/"},{"@type":"ListItem","position":3,"name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 20, n\u00ba 3\/4, 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.socesfar.es\/en\/#website","url":"https:\/\/www.socesfar.es\/en\/","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"","publisher":{"@id":"https:\/\/www.socesfar.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.socesfar.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.socesfar.es\/en\/#organization","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","url":"https:\/\/www.socesfar.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","width":383,"height":63,"caption":"Sociedad Espa\u00f1ola de Farmacolog\u00eda"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Socesfar","https:\/\/www.linkedin.com\/company\/socesfar\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/3973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista"}],"about":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/types\/revista"}],"version-history":[{"count":2,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/3973\/revisions"}],"predecessor-version":[{"id":6888,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/3973\/revisions\/6888"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media\/3952"}],"wp:attachment":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media?parent=3973"}],"wp:term":[{"taxonomy":"categoria_revista","embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/categoria_revista?post=3973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}